Beijing KeyGen Biotech

Beijing KeyGen Biotech is a precision medicine company focused on the development of advanced molecular diagnostic solutions for oncology. The company specializes in liquid biopsy and Next-Generation Sequencing (NGS) technologies to provide high-sensitivity detection of circulating tumor DNA (ctDNA). Its product portfolio includes diagnostic kits for cancer early screening, companion diagnostics, and minimal residual disease (MRD) monitoring, aimed at guiding personalized therapy and improving patient management. KeyGen Biotech leverages proprietary bioinformatics algorithms to deliver accurate genomic insights from blood samples. The company is headquartered in Beijing and has received significant backing from prominent venture capital firms to expand its clinical applications.